Orthopedics giant Zimmer Biomet entered into a definitive agreement to acquire Embody, a company that makes collagen-based implants designed to heal soft tissue injuries. Zimmer Biomet pursued the deal to grow its sports medicine portfolio and gain entry into the high-growth rotator cuff augmentation submarket, an executive said.
According to the terms of the deal, the initial purchase price of about $250 million will be paid in cash and Signify stock. The Dallas-based company will also make additional contingent payments totaling up to $50 million based on Caravan's future performance.
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
The approval of the Cigna-Express Scripts deal is also a positive signal for CVS Health's proposed $69 billion acquisition of health insurance giant Aetna.